✦ LIBER ✦

Phase II evaluation of an alternated FOLFOX/FOLFIRI regimen in patients with resistant metastatic colorectal cancer (CRC)

✍ Scribed by Hebbar, M.; Tournigand, C.; Lledo, G.; Mabro, M.; André, T.; Aparicio, T.; Flesch, M.; Varette, A.; de Gramont, A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of FOLFIRI regimen in pat

✍ Han Ying Bao; Wei Jia Fang; Xiao Chen Zhang; Gen Ming Shi; Sui Huang; Lan Fang Y 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 269 KB

Phase II Trial of Alternating mFOLFOX6 a

✍ Oki, Eiji; Emi, Yasunori; Akagi, Yoshito; Tokunaga, Shoji; Sadanaga, Noriaki; Ta 📂 Article 📅 2013 🏛 S. Karger AG 🌐 English ⚖ 150 KB

A phase II study of FOLFIRI-3 (double in

✍ Louvet, C; de Gramont, A; Mabro, M; Artru, P; André, T; Flesch, M; Maindrault-Go 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 99 KB

3046 POSTER A randomized, open-label pha

✍ T.E. Ciuleanu; W. Scheithauer; G. Kurteva; J. Ocvirk; I. Koza; D. Papamichael; M 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 55 KB

A Phase II Trial of FOLFOX6 and Cetuxima

✍ Ralph V. Boccia; Thomas M. Cosgriff; David L. Headley; Suprith Badarinath; Shake 📂 Article 📅 2010 🏛 CIG Media Group, LP. 🌐 English ⚖ 410 KB

Multicentre phase II study of bifraction

✍ Recchia, F; Saggio, G; Nuzzo, A; Lalli, A; Lullo, L Di; Cesta, A; Rea, S 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 92 KB